Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer

被引:36
作者
Jalving, M
Koornstra, JJ
De Jong, S
De Vries, EGE
Kleibeuker, JH
机构
[1] Univ Groningen Hosp, Dept Gastroenterol & Hepatol, Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Med Oncol, Groningen, Netherlands
关键词
D O I
10.1111/j.1365-2036.2005.02335.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-steroidal anti-inflammatory drugs are chemopreventive agents in colorectal cancer. Non-steroidal anti-inflammatory drugs do not, however, offer complete protection against adenoma and carcinoma development. There is increasing interest in combining non-steroidal anti-inflammatory drugs with agents that target specific cell signalling pathways in malignant and premalignant cells. This review aims to describe the current knowledge regarding the efficacy of peroxisome proliferator-activated receptor-gamma ligands, cholesterol synthesis inhibitors (statins), epidermal growth factor signalling inhibitors and tumour necrosis factor-related apoptosis-inducing ligand against colorectal neoplasms and the rationale for combining these drugs with non-steroidal anti-inflammatory drugs to improve efficacy in the chemoprevention of colorectal cancer, a PUBMED computer search of the English language literature was conducted to identify relevant papers published before July 2004. Peroxisome proliferator-activated receptor-gamma ligands and statins, both in clinical use, reduce the growth rate of human colon cancer cells in vitro and in rodents models. In vitro, preclinical in vivo and clinical studies have shown efficacy of epidermal growth factor signalling inhibition in colorectal cancer. In vitro, tumour necrosis factor-related apoptosis-inducing ligand induces apoptosis in human colon cancer cells, but not in normal cells. These drugs have all been shown to interact with non-steroidal anti-inflammatory drugs in colorectal cancer cells and/or in rodent models. Combinational regimen are a promising strategy for the chemoprevention of colorectal cancer and should be further explored.
引用
收藏
页码:321 / 339
页数:19
相关论文
共 191 条
  • [1] Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac
    Agarwal, B
    Rao, CV
    Bhendwal, S
    Ramey, WR
    Shirin, H
    Reddy, BS
    Holt, PR
    [J]. GASTROENTEROLOGY, 1999, 117 (04) : 838 - 847
  • [2] Agarwal B, 1999, CLIN CANCER RES, V5, P2223
  • [3] ALDERSON RF, 2003, P AM ASSOC CANC RES, V44, pA963
  • [4] Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
    Almasan, A
    Ashkenazi, A
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2003, 14 (3-4) : 337 - 348
  • [5] Familial relative risk of colorectal cancer: a population-based study
    Andrieu, N
    Launoy, G
    Guillois, R
    Ory-Paoletti, C
    Gignoux, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (13) : 1904 - 1911
  • [6] Apoptosis control by death and decoy receptors
    Ashkenazi, A
    Dixit, VM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 255 - 260
  • [7] Safety and antitumor activity of recombinant soluble Apo2 ligand
    Ashkenazi, A
    Pai, RC
    Fong, S
    Leung, S
    Lawrence, DA
    Masters, SA
    Blackie, C
    Chang, L
    McMurtrey, AE
    Hebert, A
    DeForge, L
    Koumenis, IL
    Lewis, D
    Harris, L
    Bussiere, J
    Koeppen, H
    Shahrokh, Z
    Schwall, RH
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) : 155 - 162
  • [8] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [9] RETRACTED: Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor γ (Retracted article.: See vol. 65, pg. 8057, 2005)
    Badawi, AF
    Eldeen, MB
    Liu, YY
    Ross, EA
    Badr, MZ
    [J]. CANCER RESEARCH, 2004, 64 (03) : 1181 - 1189
  • [10] Calcium supplements for the prevention of colorectal adenomas
    Baron, JA
    Beach, M
    Mandel, JS
    van Stolk, RU
    Haile, RW
    Sandler, RS
    Rothstein, R
    Summers, RW
    Snover, DC
    Beck, GJ
    Bond, JH
    Greenberg, ER
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) : 101 - 107